Expression of PD-L1 and BCG immunotherapy in non-muscle invasive bladder cancer

被引：2
|
作者：
Heo, Jun Hyeok
Jin, Hyun A.
Kang, You Hyun
Kim, Ki Hong
Hong, Sung Joon
Han, Kyung Seok
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.TME16-A16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A16
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PD-L1 EXPRESSION AND BCG RESPONSE IN NON-MUSCLE INVASIVE BLADDER CANCER
    Woldu, Solomon
    Gerald, Thomas
    Margulis, Vitaly
    Halstuch, Daniel
    Ber, Yaara
    Lifshitz, Karin
    Margel, David
    Tikva, Petah
    Lotan, Yair
    Jia, Liwei
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1003 - E1003
  • [2] PD-L1 Expression Correlates with Lack of Response to BCG Therapy in Non-Muscle Invasive Bladder Cancer
    Matoso, Andres
    Baras, Alexander
    Kates, Max
    Bivalacqua, Trinity J.
    Cimino-Mathews, Ashley
    Epstein, Jonathan
    MODERN PATHOLOGY, 2018, 31 : 366 - 366
  • [3] PD-L1 Expression Correlates with Lack of Response to BCG Therapy in Non-Muscle Invasive Bladder Cancer
    Matoso, Andres
    Baras, Alexander
    Kates, Max
    Bivalacqua, Trinity J.
    Cimino-Mathews, Ashley
    Epstein, Jonathan
    LABORATORY INVESTIGATION, 2018, 98 : 366 - 366
  • [4] PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG
    de Jong, Florus C.
    Kvikstad, Vebjorn
    Hoedemaeker, Robert F.
    van der Made, Angelique C. J.
    van der Bosch, Thierry P.
    van Casteren, Niels J.
    van Kessel, Kim E. M.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Zuiverloon, Tahlita C. M.
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
  • [5] PD-L1/PD-1 expression as a predictor of response to BCG in patients with high-risk non-muscle invasive bladder cancer.
    Roumiguie, Mathieu
    Comperat, Eva
    Neuzillet, Yann
    Nouhaud, Francois-Xavier
    Graffeille, Vivien
    Masson-Lecomte, Alexandra
    Colin, Pierre
    Audenet, Francois
    Houede, Nadine
    Larre, Stephane
    Xylinas, Evanguelos
    Thomassin, Jeanne Piana
    Cotte, Juliette
    Pignot, Geraldine
    Chaltiel, Leonor
    Roupret, Morgan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Impulsive control dosing BCG immunotherapy for non-muscle invasive bladder cancer
    Saadi S.
    Elmouki I.
    Hamdache A.
    International Journal of Dynamics and Control, 2015, 3 (3) : 313 - 323
  • [7] Immunotherapy for non-muscle invasive bladder cancer
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [8] IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Black, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 37 - 37
  • [9] PD-L1 expression and BCG response in nonmuscle invasive bladder cancer.
    Woldu, Solomon L.
    Gerald, Thomas
    Margulis, Vitaly
    Halstuch, Daniel
    Ber, Yaara
    Lifshitz, Karin
    Margel, David
    Lotan, Yair
    Jia, Liwei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer
    Chunxiao Chen
    Zehai Huang
    Pengcheng Huang
    Kun Li
    Jiarong Zeng
    Yuehui Wen
    Biao Li
    Jie Zhao
    Peng Wu
    BMC Microbiology, 22
12345